Mapping the New Prescription Price Maze

Prescription drugs are becoming one of the largest expenses for retirees. Seniors now spend roughly 15% of their budgets on healthcare, and drug costs continue to rise faster than overall inflation.

The drug price system has become increasingly complex. Patients must navigate insurance formularies, pharmacy pricing differences, discount platforms, and government programs.

According to KFF, 1 in 5 adults say they have skipped filling a prescription because of cost.

Government policy is undergoing a shift. Medicare now negotiates prices directly with drug manufacturers, lowering costs on the first ten medications including diabetes treatment from Merck $MRK ( ▼ 0.24% ) and arthritis drug Enbrel produced by Amgen $AMGN ( ▲ 0.53% ). A separate rule caps insulin costs at $35 per month for covered products.

Medicare drug coverage itself also changed. Beginning in 2025, out-of-pocket spending for prescription drugs is capped. In 2026, the annual limit is $2,100, offering relief to patients with expensive medications.

But the biggest savings often come from comparison shopping. Coupon platforms like GoodRx and the government-backed TrumpRx can lower cash prices on many medications.

Retailers are also competing aggressively. Costco $COST ( ▲ 1.58% ), Walmart $WMT ( ▲ 0.4% ), and Amazon $AMZN ( ▼ 2.62% ) all offer discounted prescriptions and delivery options.

Another lever is switching to generics whenever possible. Even when insurance covers only a brand-name drug, a generic equivalent purchased outside the plan may cost less.

The catch is that these discounts usually do not count toward Medicare deductibles or the annual spending cap. Patients must calculate which option produces the lowest total cost over the year.

Prescription pricing in America remains complex. But for patients willing to compare plans, pharmacies, and coupons, meaningful savings are often hiding in plain sight.